|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-6-18
|
|
pubmed:abstractText |
To investigate the relative contribution of MHC loci in their susceptibility to primary ankylosing spondylitis (AS) in HLA-B27 negative patients and to compare the clinical features and genetic factors with those of HLA-B27 positive AS.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1288-93
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11409121-Adult,
pubmed-meshheading:11409121-Female,
pubmed-meshheading:11409121-Genetic Predisposition to Disease,
pubmed-meshheading:11409121-HLA-B27 Antigen,
pubmed-meshheading:11409121-Histocompatibility Antigens Class I,
pubmed-meshheading:11409121-Histocompatibility Testing,
pubmed-meshheading:11409121-Humans,
pubmed-meshheading:11409121-Male,
pubmed-meshheading:11409121-Polymorphism, Genetic,
pubmed-meshheading:11409121-Promoter Regions, Genetic,
pubmed-meshheading:11409121-Spondylitis, Ankylosing,
pubmed-meshheading:11409121-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.
|
|
pubmed:affiliation |
Department of Immunology, Hospital Central de Asturias, E-33006 Oviedo, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
